Hyaluronic Acid Based Dermal Fillers Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	177 Pages	Fortune Business Insights Pvt. Ltd.	June, 2024	FOB18867073

Best Price Guarantee
Price	from $4,850
Length	177 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	June, 2024
SKU	FOB18867073

Hyaluronic Acid Based Dermal Fillers Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Hyaluronic Acid Based Dermal Fillers Market

The hyaluronic acid based dermal fillers market size was valued at USD 3.88 billion in 2022, and the market is now projected to grow from USD 4.13 billion in 2023 to USD 7.15 billion by 2030, exhibiting a CAGR of 8.9% during the forecast period of 2023-2030.

The marketplace of hyaluronic acid-primarily based dermal fillers became now not useful within the year 2020 because the COVID-19 virus outbreak severely impacted the marketplace. This is why non-invasive surgeries were ceased, and the admission rate of anti-aging treatment was never high during the period of pandemic. This COVID-19 virus affects various categories of industries, and because of the virus outbreak, there were challenges in producing raw HA. The possibly affected areas' closure by the government in a bid to contain the virus spread unwillingly impacted the chain of hyaluronic acid and thus exerted a negative impact on the hyaluronic acid based dermal fillers market growth.

HA has recently become an important tool in all treatments that are related to cosmetics, especially because it makes the skin moisturized and filled which is employed during anti-aging treatments that do not require surgery. This is because the societal desire towards an aesthetically preferable youthful look persists and people will do all that is possible to achieve smooth skin which has led to the development of HA fillers as a minimally invasive procedure in the dermatology system and is expected to elevate the system and grow the market. Similarly, the availability of extensive numbers of hospitals and specialized dermatological centres offering various cosmetic treatments inclusive to dermal fillers formulated with HA all over the world has been assumed to propel the market. There are also many new products that have been approved which in one way or another has altered the entire mode of the industry and the approved list of products is still expanding. Each of the aforementioned factors has an impact on the hyaluronic acid based dermal fillers market share.

Producers who are new to the market have observed this incidence of the youthful folks getting the filler procedures carried out and have provided you with their merchandise which can be made from HA-based fillers. Some of the elements which include improving human beings’s perception of beauty among the people, and the advent of particular stylish merchandise and items in particular for teenagers due to the seasonal trade inside the fashion industry are expected to push the overall marketplace forward in the future years.

Comprehensive Analysis of Hyaluronic Acid Based Dermal Fillers Market

The well-rounded market study of hyaluronic acid-based dermal fillers entails the market classification by crosslinking type, application, and end client. According to the type of crosslinking, it includes the monophasic and biphasic fillers which are used according to texture or hardness. Applicators of the market also include scar treatment, wrinkle correction treatment, lip enhancement, and restoration of volume fullness and some of the key end users of the market are specialty and dermatology clinics hospitals clinics, or other healthcare provider organizations.

The centered market of North America is worth USD 1. 64 billion in 2022 and is anticipated to grow at an awesome tempo for the duration of the span of the identical duration. The compound increase is because monophasic offerings are quickly getting followed, having a nicely-evolved healthcare gadget, and substantial research and development sports by way of key players.

Allergan Aesthetics (AbbVie ) (U.S.), Revance Therapeutics, Inc. (U.S.), Merz Pharma (Germany), Galderma (Switzerland), Sinclair Pharma (U.K.), BIOPLUS CO.LTD. (South Korea), Bioxis Pharmaceuticals (France), DR. Korman (Israel), Prollenium Medical Technologies (Canada), and Teoxane (Switzerland) are some players on this company. These businesses of organizations who are leaders in the discipline offer a level gambling region for all their opposition as they guarantee increase and set necessities for the area.

In February 2023, ALLERGAN (AbbVie) introduced JUVEDERM VOLUX XC for the management of mild to severe jaw transformation in adults over 21 years of age.

Segmentation Table

Global Hyaluronic Acid Based Dermal Fillers Market Scope

Study Period 2019-2030

Base Year 2022

Estimated Year 2023

Forecast Period 2023-2030

Historical Period 2019-2021

Growth Rate CAGR of 8.1% From 2023-2030

Unit Value (USD billion)

Segmentation By Crosslinking Type, Application, End-user, and Region

By Crosslinking TypeMonophasic

Biphasic

ByApplication Scar Treatment

Wrinkle Correction Treatment

Lip Enhancement

Restoration of Volume/Fullness

Others

ByEnd-userSpecialty & Dermatology Clinics

Hospitals & Clinics

Others

By Region North America (By Crosslinking Type, By Application, By End-user, and By Country)

- U.S. (By Application)

- Canada (By Application)

Europe (By Crosslinking Type, By Application, By End-user, and By Country)

- U.K. (By Application)

- Germany (By Application)

- France (By Application)

- Italy (By Application)

- Spain (By Application)

- Scandinavia (By Application)

- Rest of Europe (By Application)

Asia Pacific (By Crosslinking Type, By Application, By End-user, and By Country)

- Japan (By Application)

- China (By Application)

- India (By Application)

- Australia (By Application)

- Southeast Asia (By Application)

- Rest of Asia Pacific (By Application)

Latin America (By Crosslinking Type, By Application, By End-user, and By Country)

- Brazil (By Application)

- Mexico (By Application)

- Rest of Latin America (By Application)

Middle East & Africa (By Crosslinking Type, By Application, By End-user, and By Country)

- South Africa (By Application)

- GCC (By Application)

- Rest of Middle East & Africa (By Application)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Overview of the Number of Hyaluronic Acid Based Dermal Fillers Procedures by Key Countries; 4.2. Overview of Regulatory Scenario by Key Countries; 4.3. Overview of Reimbursement Scenario by Key Countries; 4.4. New Product Launches; 4.5. Pipeline Analysis; 4.6. Key Industry Developments; 4.7. Supply Chain Analysis; 4.8. Pricing of Key Brands, By Region; 4.9. Insights: Technical Challenges Regarding Commercialization of HA Based Dermal Fillers; 4.10. Manufacturing Locations for Key Brands; 4.11. Impact of COVID-19 on the Market
5. Global Hyaluronic Acid Based Dermal Fillers Market Analysis, Insights and Forecast, 2019-2030: 5.1. Market Analysis, Insights and Forecast – By Crosslinking Type; 5.1.1. Monophasic; 5.1.2. Biphasic; 5.2. Market Analysis, Insights and Forecast – By Application; 5.2.1. Scar Treatment; 5.2.2. Wrinkle Correction Treatment; 5.2.3. Lip Enhancement; 5.2.4. Restoration of Volume/ Fullness; 5.2.5. Others; 5.3. Market Analysis, Insights and Forecast – By End-user; 5.3.1. Specialty & Dermatology Clinics; 5.3.2. Hospitals & Clinics; 5.3.3. Others; 5.4. Market Analysis, Insights and Forecast – By Region; 5.4.1. North America; 5.4.2. Europe; 5.4.3. Asia Pacific; 5.4.4. Latin America; 5.4.5. Middle East & Africa
6. North America Hyaluronic Acid Based Dermal Fillers Market Analysis, Insights and Forecast, 2019-2030: 6.1. Market Analysis, Insights and Forecast – By Crosslinking Type; 6.1.1. Monophasic; 6.1.2. Biphasic; 6.2. Market Analysis, Insights and Forecast – By Application; 6.2.1. Scar Treatment; 6.2.2. Wrinkle Correction Treatment; 6.2.3. Lip Enhancement; 6.2.4. Restoration of Volume/ Fullness; 6.2.5. Others; 6.3. Market Analysis, Insights and Forecast – By End-user; 6.3.1. Specialty & Dermatology Clinics; 6.3.2. Hospitals & Clinics; 6.3.3. Others; 6.4. Market Analysis, Insights and Forecast – By Country; 6.4.1. U.S.; 6.4.1.1. By Application; 6.4.2. Canada; 6.4.2.1. By Application
7. Europe Hyaluronic Acid Based Dermal Fillers Market Analysis, Insights and Forecast, 2019-2030: 7.1. Market Analysis, Insights and Forecast – By Crosslinking Type; 7.1.1. Monophasic; 7.1.2. Biphasic; 7.2. Market Analysis, Insights and Forecast – By Application; 7.2.1. Scar Treatment; 7.2.2. Wrinkle Correction Treatment; 7.2.3. Lip Enhancement; 7.2.4. Restoration of Volume/ Fullness; 7.2.5. Others; 7.3. Market Analysis, Insights and Forecast – By End-user; 7.3.1. Specialty & Dermatology Clinics; 7.3.2. Hospitals & Clinics; 7.3.3. Others; 7.4. Market Analysis, Insights and Forecast – By Country/Sub-region; 7.4.1. U.K.; 7.4.1.1. By Application; 7.4.2. Germany; 7.4.2.1. By Application; 7.4.3. France; 7.4.3.1. By Application; 7.4.4. Italy; 7.4.4.1. By Application; 7.4.5. Spain; 7.4.5.1. By Application; 7.4.6. Scandinavia; 7.4.6.1. By Application; 7.4.7. Rest of Europe; 7.4.7.1. By Application
8. Asia Pacific Hyaluronic Acid Based Dermal Fillers Market Analysis, Insights and Forecast, 2019-2030: 8.1. Market Analysis, Insights and Forecast – By Crosslinking Type; 8.1.1. Monophasic; 8.1.2. Biphasic; 8.2. Market Analysis, Insights and Forecast – By Application; 8.2.1. Scar Treatment; 8.2.2. Wrinkle Correction Treatment; 8.2.3. Lip Enhancement; 8.2.4. Restoration of Volume/ Fullness; 8.2.5. Others; 8.3. Market Analysis, Insights and Forecast – By End-user; 8.3.1. Specialty & Dermatology Clinics; 8.3.2. Hospitals & Clinics; 8.3.3. Others; 8.4. Market Analysis, Insights and Forecast – By Country/Sub-region; 8.4.1. Japan; 8.4.1.1. By Application; 8.4.2. China; 8.4.2.1. By Application; 8.4.3. India; 8.4.3.1. By Application; 8.4.4. Australia; 8.4.4.1. By Application; 8.4.5. Southeast Asia; 8.4.5.1. By Application; 8.4.6. Rest of Asia Pacific; 8.4.6.1. By Application
9. Latin America Hyaluronic Acid Based Dermal Fillers Market Analysis, Insights and Forecast, 2019-2030: 9.1. Market Analysis, Insights and Forecast – By Crosslinking Type; 9.1.1. Monophasic; 9.1.2. Biphasic; 9.2. Market Analysis, Insights and Forecast – By Application; 9.2.1. Scar Treatment; 9.2.2. Wrinkle Correction Treatment; 9.2.3. Lip Enhancement; 9.2.4. Restoration of Volume/ Fullness; 9.2.5. Others; 9.3. Market Analysis, Insights and Forecast – By End-user; 9.3.1. Specialty & Dermatology Clinics; 9.3.2. Hospitals & Clinics; 9.3.3. Others; 9.4. Market Analysis, Insights and Forecast – By Country/Sub-region; 9.4.1. Brazil; 9.4.1.1. By Application; 9.4.2. Mexico; 9.4.2.1. By Application; 9.4.3. Rest of Latin America; 9.4.3.1. By Application
10. Middle East & Africa Hyaluronic Acid Based Dermal Fillers Market Analysis, Insights and Forecast, 2019-2030: 10.1. Market Analysis, Insights and Forecast – By Crosslinking Type; 10.1.1. Monophasic; 10.1.2. Biphasic; 10.2. Market Analysis, Insights and Forecast – By Application; 10.2.1. Scar Treatment; 10.2.2. Wrinkle Correction Treatment; 10.2.3. Lip Enhancement; 10.2.4. Restoration of Volume/ Fullness; 10.2.5. Others; 10.3. Market Analysis, Insights and Forecast – By End-user; 10.3.1. Specialty & Dermatology Clinics; 10.3.2. Hospitals & Clinics; 10.3.3. Others; 10.4. Market Analysis, Insights and Forecast – By Country/Sub-region; 10.4.1. South Africa; 10.4.1.1. By Application; 10.4.2. GCC; 10.4.2.1. By Application; 10.4.3. Rest of Middle East & Africa; 10.4.3.1. By Application
11. Competitive Analysis: 11.1. Global Market Share Analysis (2022); 11.2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability)); 11.2.1. Allergan Aesthetics (AbbVie Inc.); 11.2.1.1. Overview,; 11.2.1.2. Product,; 11.2.1.3. SWOT Analysis,; 11.2.1.4. Recent Developments,; 11.2.1.5. Strategies,; 11.2.1.6. Financials (Based on Availability); 11.2.2. Revance Therapeutics, Inc.; 11.2.2.1. Overview,; 11.2.2.2. Product,; 11.2.2.3. SWOT Analysis,; 11.2.2.4. Recent Developments,; 11.2.2.5. Strategies,; 11.2.2.6. Financials (Based on Availability); 11.2.3. Merz Pharma; 11.2.3.1. Overview,; 11.2.3.2. Product,; 11.2.3.3. SWOT Analysis,; 11.2.3.4. Recent Developments,; 11.2.3.5. Strategies,; 11.2.3.6. Financials (Based on Availability); 11.2.4. Galderma; 11.2.4.1. Overview,; 11.2.4.2. Product,; 11.2.4.3. SWOT Analysis,; 11.2.4.4. Recent Developments,; 11.2.4.5. Strategies,; 11.2.4.6. Financials (Based on Availability); 11.2.5. Sinclair Pharma; 11.2.5.1. Overview,; 11.2.5.2. Product,; 11.2.5.3. SWOT Analysis,; 11.2.5.4. Recent Developments,; 11.2.5.5. Strategies,; 11.2.5.6. Financials (Based on Availability); 11.2.6. BIOPLUS CO., LTD.; 11.2.6.1. Overview,; 11.2.6.2. Product,; 11.2.6.3. SWOT Analysis,; 11.2.6.4. Recent Developments,; 11.2.6.5. Strategies,; 11.2.6.6. Financials (Based on Availability); 11.2.7. Bioxis pharmaceuticals; 11.2.7.1. Overview,; 11.2.7.2. Product,; 11.2.7.3. SWOT Analysis,; 11.2.7.4. Recent Developments,; 11.2.7.5. Strategies,; 11.2.7.6. Financials (Based on Availability); 11.2.8. SCULPT Luxury Dermal Fillers LTD; 11.2.8.1. Overview,; 11.2.8.2. Product,; 11.2.8.3. SWOT Analysis,; 11.2.8.4. Recent Developments,; 11.2.8.5. Strategies,; 11.2.8.6. Financials (Based on Availability); 11.2.9. DR. Korman; 11.2.9.1. Overview,; 11.2.9.2. Product,; 11.2.9.3. SWOT Analysis,; 11.2.9.4. Recent Developments,; 11.2.9.5. Strategies,; 11.2.9.6. Financials (Based on Availability); 11.2.10. Prollenium Medical Technologies; 11.2.10.1. Overview,; 11.2.10.2. Product,; 11.2.10.3. SWOT Analysis,; 11.2.10.4. Recent Developments,; 11.2.10.5. Strategies,; 11.2.10.6. Financials (Based on Availability); 11.2.11. Teoxane; 11.2.11.1. Overview,; 11.2.11.2. Product,; 11.2.11.3. SWOT Analysis,; 11.2.11.4. Recent Developments,; 11.2.11.5. Strategies,; 11.2.11.6. Financials (Based on Availability)